Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Lisa A. Kosmiski"'
Autor:
Peter Bacchetti, Rebecca Scherzer, Phyllis C. Tien, Carl Grunfeld, Carmen A. Peralta, Michael G. Shlipak, Lisa A. Kosmiski, Anna Malkina
Publikováno v:
HIV Medicine. 16:184-190
Author(s): Malkina, A; Scherzer, R; Shlipak, MG; Bacchetti, P; Tien, PC; Grunfeld, C; Kosmiski, L; Peralta, CA | Abstract: ObjectivesThe aim of the study was to investigate the association of adiposity with longitudinal kidney function change in 544
Influence of CYP2C8*2 on the Pharmacokinetics of Pioglitazone in Healthy African-American Volunteers
Autor:
Lisa A. Kosmiski, Julie A. Predhomme, Samantha H. Spencer, Michael F. Wempe, Christina L. Aquilante, Maha S. Sidhom
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 33:1000-1007
Study Objectives To determine the influence of the Cytochrome P450 (CYP) 2C8*2 polymorphism on pioglitazone pharmacokinetics in healthy African-American volunteers. Design Prospective, open-label, single-dose pharmacokinetic study. Setting University
Autor:
Merry Le, Maha S. Sidhom, David W. A. Bourne, Charles W. Hopley, Kyle P. Hammond, Julie A. Predhomme, Uday B. Kompella, Alexander T. Kanack, Elizabeth B. Daily, Lane R. Bushman, Joseph E. Rower, Rajendra S. Kadam, Christina L. Aquilante, Lisa A. Kosmiski
Publikováno v:
British Journal of Clinical Pharmacology. 75:217-226
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • A drug–drug interaction exists between gemfibrozil (CYP2C8 inhibitor) and pioglitazone (CYP2C8 substrate), whereby gemfibrozil increases pioglitazone plasma exposure. Substantial interindividual variabil
Autor:
Ronald L. Prigeon, Julie A. Predhomme, Anh Vu, Christina L. Aquilante, Kimberly M. Deininger, Maha S. Sidhom, Lisa A. Kosmiski, Brooke C Bredbeck, Amber L. Beitelshees
Publikováno v:
Pharmacotherapy. 36(3)
Study Objective To determine the effects of low-dose pioglitazone on plasma adipocyte-derived cytokines, high-sensitivity C-reactive protein (hs-CRP), and components of the metabolic syndrome in adults with the metabolic syndrome without diabetes mel
Autor:
Lisa A. Kosmiski
Publikováno v:
The American Journal of Clinical Nutrition. 94:1677S-1682S
Energy intake recommendations for adults should be based preferably on direct measurements of total daily energy expenditure (TDEE) in corresponding populations who are maintaining healthy body weight and satisfactory physical activity levels. During
Autor:
Mary L. Biggs, Lisa A. Kosmiski, Rebecca Scherzer, Michael S. Simberkoff, Steven B. Heymsfield, Peter Bacchetti, Michael G. Shlipak, David Rimland, Stephen Sidney, Carl Grunfeld, Metabolic Change in Hiv Infection
Publikováno v:
Diabetes Care
Diabetes care, vol 34, iss 11
Diabetes care, vol 34, iss 11
OBJECTIVE Changes in body fat distribution and abnormal glucose metabolism are common in HIV-infected patients. We hypothesized that HIV-infected participants would have a higher prevalence of impaired glucose tolerance (IGT) compared with control su
Publikováno v:
Pharmacotherapy. 30:236-247
Study Objectives. To determine the effects of the thiazolidinedione rosiglitazone on the adipocyte-derived cytokines adiponectin (an antiinflammatory and insulin-sensitizing cytokine; low levels have been associated with metabolic syndrome) and resis
Autor:
Cora E. Lewis, Rebecca Scherzer, Steven B. Heymsfield, Donald P. Kotler, Michael G. Shlipak, Peter Bacchetti, Lisa A. Kosmiski, Carl Grunfeld
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 93:216-224
HIV-infected patients receiving antiretroviral therapy often develop changes in body fat distribution; the dominant change is reduction in sc adipose tissue (SAT). Because adipose tissue makes important hormones involved in whole-body energy metaboli
Publikováno v:
The American Journal of Clinical Nutrition. 86:1009-1015
BACKGROUND HIV lipodystrophy and other lipodystrophy syndromes are characterized by extensive loss of subcutaneous adipose tissue. Lipodystrophy syndromes are also associated with increased resting energy expenditure (REE). This hypermetabolism may b
Publikováno v:
Antiviral Therapy. 11:187-196
The use of nucleoside reverse transcriptase inhibitors (NRTIs) for the treatment of HIV infection is clearly linked to the development of subcutaneous fat atrophy. Until recently, however, in vitro studies of adipocytes have shown no or only modest a